198 related articles for article (PubMed ID: 31642777)
1. Receptor-Interacting Protein Kinase 1 (RIPK1) as a Potential Therapeutic Target: An Overview of Its Possible Role in the Pathogenesis of Alzheimer's Disease.
Chan HH; Koh RY; Lim CL; Leong CO
Curr Alzheimer Res; 2019; 16(10):907-918. PubMed ID: 31642777
[TBL] [Abstract][Full Text] [Related]
2. Roles of receptor-interacting protein kinase 1 in SH-SY5Y cells with beta amyloid-induced neurotoxicity.
Chan HH; Leong CO; Lim CL; Koh RY
J Cell Mol Med; 2022 Mar; 26(5):1434-1444. PubMed ID: 35106914
[TBL] [Abstract][Full Text] [Related]
3. Novel insights into RIPK1 as a promising target for future Alzheimer's disease treatment.
Li S; Qu L; Wang X; Kong L
Pharmacol Ther; 2022 Mar; 231():107979. PubMed ID: 34480965
[TBL] [Abstract][Full Text] [Related]
4. The PKR/P38/RIPK1 Signaling Pathway as a Therapeutic Target in Alzheimer's Disease.
Hugon J; Paquet C
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33808629
[TBL] [Abstract][Full Text] [Related]
5. RIPK1 mediates a disease-associated microglial response in Alzheimer's disease.
Ofengeim D; Mazzitelli S; Ito Y; DeWitt JP; Mifflin L; Zou C; Das S; Adiconis X; Chen H; Zhu H; Kelliher MA; Levin JZ; Yuan J
Proc Natl Acad Sci U S A; 2017 Oct; 114(41):E8788-E8797. PubMed ID: 28904096
[TBL] [Abstract][Full Text] [Related]
6. IKKβ Alleviates Neuron Injury in Alzheimer's Disease via Regulating Autophagy and RIPK1-Mediated Necroptosis.
Wang W; Gu X; Cheng Z; Lu X; Xie S; Liu X
Mol Neurobiol; 2022 Apr; 59(4):2407-2423. PubMed ID: 35083662
[TBL] [Abstract][Full Text] [Related]
7. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M
Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971
[TBL] [Abstract][Full Text] [Related]
8. Autophagic dysfunction in Alzheimer's disease: Cellular and molecular mechanistic approaches to halt Alzheimer's pathogenesis.
Uddin MS; Mamun AA; Labu ZK; Hidalgo-Lanussa O; Barreto GE; Ashraf GM
J Cell Physiol; 2019 Jun; 234(6):8094-8112. PubMed ID: 30362531
[TBL] [Abstract][Full Text] [Related]
9. The Receptor-interacting Serine/Threonine Protein Kinase 1 (RIPK1) Regulates Progranulin Levels.
Mason AR; Elia LP; Finkbeiner S
J Biol Chem; 2017 Feb; 292(8):3262-3272. PubMed ID: 28069809
[TBL] [Abstract][Full Text] [Related]
10. Molecular and functional characteristics of receptor-interacting protein kinase 1 (RIPK1) and its therapeutic potential in Alzheimer's disease.
Pati S; Singh Gautam A; Dey M; Tiwari A; Kumar Singh R
Drug Discov Today; 2023 Dec; 28(12):103750. PubMed ID: 37633326
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
12. The Implications of Autophagy in Alzheimer's Disease.
Hamano T; Hayashi K; Shirafuji N; Nakamoto Y
Curr Alzheimer Res; 2018; 15(14):1283-1296. PubMed ID: 30289076
[TBL] [Abstract][Full Text] [Related]
13. Targeting Necroptosis as a Promising Therapy for Alzheimer's Disease.
Zhao W; Liu Y; Xu L; He Y; Cai Z; Yu J; Zhang W; Xing C; Zhuang C; Qu Z
ACS Chem Neurosci; 2022 Jun; 13(12):1697-1713. PubMed ID: 35607807
[TBL] [Abstract][Full Text] [Related]
14. Mammalian target of rapamycin: a valid therapeutic target through the autophagy pathway for Alzheimer's disease?
Cai Z; Zhao B; Li K; Zhang L; Li C; Quazi SH; Tan Y
J Neurosci Res; 2012 Jun; 90(6):1105-18. PubMed ID: 22344941
[TBL] [Abstract][Full Text] [Related]
15. Multiple roles for glycogen synthase kinase-3 as a drug target in Alzheimer's disease.
Huang HC; Klein PS
Curr Drug Targets; 2006 Nov; 7(11):1389-97. PubMed ID: 17100579
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
17. Key Peptides and Proteins in Alzheimer's Disease.
Penke B; Bogár F; Paragi G; Gera J; Fülöp L
Curr Protein Pept Sci; 2019; 20(6):577-599. PubMed ID: 30605056
[TBL] [Abstract][Full Text] [Related]
18. Temsirolimus promotes autophagic clearance of amyloid-β and provides protective effects in cellular and animal models of Alzheimer's disease.
Jiang T; Yu JT; Zhu XC; Tan MS; Wang HF; Cao L; Zhang QQ; Shi JQ; Gao L; Qin H; Zhang YD; Tan L
Pharmacol Res; 2014 Mar; 81():54-63. PubMed ID: 24602800
[TBL] [Abstract][Full Text] [Related]
19. Targeting autophagy in Alzheimer's disease: Animal models and mechanisms.
Zhang XW; Zhu XX; Tang DS; Lu JH
Zool Res; 2023 Nov; 44(6):1132-1145. PubMed ID: 37963840
[TBL] [Abstract][Full Text] [Related]
20. Novel disease-modifying therapies for Alzheimer's disease.
Jiang T; Yu JT; Tan L
J Alzheimers Dis; 2012; 31(3):475-92. PubMed ID: 22669013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]